AstraZeneca

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.

Cancer (Illustrative)
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US to move COVID-19 vaccines, treatments to private markets in 2023

AION Labs CEO Mati Gil.

AION, aMoon up for top scientific innovation award

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

COVID-19 booster shots are crucial, according to a Yale study


3 health staff receive AstraZeneca vaccine, hospitalized in Norway

Norway halted on Thursday the rollout of that vaccine, following a similar move by Denmark. Iceland later followed suit.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

Thailand delays AstraZeneca vaccination amid Europe safety reports

The locally made AstraZeneca is not due to be ready until at least June, and Thailand last week began limited inoculations with imported doses of the Sinovac vaccine.

The logo of AstraZeneca is seen on medication packages in a pharmacy in London

Romania pauses use of AstraZeneca COVID-19 vaccine batch

Romanian officials said the country did not receive doses from the batch suspended in Denmark and other states.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

Denmark suspends AstraZeneca COVID vaccine after blood clot reports

They said six other European countries had halted the use of a vaccine batch from AstraZeneca.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Austria suspends AstraZeneca COVID-19 vaccine batch after death

One 49-year-old woman died as a result of severe coagulation disorders, while a 35-year-old woman developed a pulmonary embolism and is recovering.

A healthcare worker hands over doses of the Pfizer-BioNTech COVID-19 vaccine to a doctor at Messe Wien Congress Center, which has been set up as coronavirus disease vaccination centre, in Vienna, Austria February 7, 2021.

South Korea probing two deaths after AstraZeneca's COVID-19 vaccine

A 63-year-old nursing home patient with cerebrovascular disease developed symptoms, including high fever, after being given the AstraZeneca vaccine.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

India to send 25,000 vaccines to Palestinians amid global shortage

The PA has received only some 32,000 doses for its population in Gaza and the West Bank.

A Palestinian health worker prepares to vaccinate Matthias Schmale, UNRWA's Gaza director, against the coronavirus disease (COVID-19), in Gaza City February 24, 2021.

Middle East Boosts Vaccination Efforts

Afghanistan starts inoculation drive among other regional improvements, Lebanese legislators jump queue

A medical worker holds a syringe with Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) before administering an injection at a vaccination centre in a shopping mall in Saint Petersburg, Russia February 24, 2021.

COVID-19: AstraZeneca vaccine stronger if 3 months between doses - study

The findings are not without precedent, with the study noting that other vaccines, like those for the flu, Ebola and malaria, also provide greater protection after longer intervals between doses.

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

AstraZeneca to miss 2nd-quarter EU vaccine supply by half - EU Official

AstraZeneca's contract with the EU, which was leaked last week, showed the company had committed to delivering 180 million doses to the 27-nation bloc in the second quarter.

The logo of AstraZeneca is seen on medication packages in a pharmacy in London